Searched for
POSTMENOPAUSAL OSTEOPOROSIS
Biocon shares rise 2% after USFDA approval for osteoporosis and bone loss drugsShares of Biocon Ltd rose 2% to Rs 361.25 on the BSE after its subsidiary, Biocon Biologics, received U.S. FDA approval for two denosumab b...- Biocon Biologics gets UK MHRA nod for biosimilars Vevzuo, EvfraxyBiocon Biologics Ltd has achieved a significant milestone. It has secured marketing authorizations in the UK for Vevzuo and Evfraxy. These ...
- Daily consumption of sugary drinks leads to higher risk of liver cancer in women: StudyWomen who consume sugar-sweetened beverages daily are at a higher risk of developing liver cancer and chronic liver disease mortality, as f...
- 3 out of 5 women over 40 suffer from low bone density condition osteopenia, says Mumbai-based studyThe same study found that 1 in 4 women is diagnosed with osteoporosis.
- Air pollution speeds up bone loss from osteoporosis: Study
- Lupin inks licensing pact with Japan-based I'rom GroupDenosumab is indicated for the treatment of postmenopausal women with osteoporosis at high risk of fracture and prevention of skeletal-rela...
- Men can also get osteoporosis; have nuts, dairy products, veggies to reduce bone lossOsteoporotic bones become porous and weaker, increasing the risk of fractures.
- Leprosy drug to treat cancer? Doctors hunt for new uses of old medicinesCDRI in Lucknow, scientists recently found that certain leprosy drugs might help treat myeloma, a type of blood cancer.
- Lupin launches Amabelz tablets in US marketThe company's product is indicated in a woman with a uterus for treatment of moderate to severe vasomotor symptoms due to menopause and pre...
- Dr Reddy's Laboratories inks pact with Amgen to commercialise three drugs in IndiaUnder the terms, DRL will commercialise Xgeva (denosumab), Vectibix (panitumumab) and Prolia (denosumab) in India, a company statement said...
- Lupin launches generic Femhrt tablets in USDrug firm Lupin has launched its generic norethindrone acetate and ethinyl estradiol tablets used for the prevention of postmenopausal oste...
- Aurobindo Pharma gets USFDA nod for osteoporosis drug"The approved product has an estimated market size of USD 96 million for the twelve months ended January 2016 according to IMS," it said.
- Aurobindo Pharma gets final USFDA nod for osteoporosis drugDrug firm Aurobindo Pharma has received final approval from USFDA to manufacture and market Ibandronate Sodium tablets, in the American mar...
- Sun Pharma recalls 3.8 lakh cartons of osteoporosis drug in USThe recall of 3,81,120 cartons of Alendronate Sodium tablets has been initiated by Sun Pharma Global Fze, an arm of the Indian pharma major.
- Lupin gets FDA approval for generic Femhrt tabletsThe company has received received the final approval from the United States Food and Drug Administration to market Fyavolv tablets, it said.
- Aurobindo Pharma gains on USFDA approval for generic osteoporosis drugShares of Aurobindo Pharma gained 3.3 per cent in trade on Monday, after the company got US FDA nod for generic osteoporosis drug.
- Aurobindo Pharma gets US FDA nod for generic osteoporosis drugAurobindo Pharma has received approval from the US FDA to manufacture and market its generic version of Eli Lilly's Evista tablets used to ...
- Two inexpensive generic drugs can reduce breast cancer deathsThe studies, both published in The Lancet, suggest that two types of drugs, aromatase inhibitors (AIs) and bisphosphonates, can be used tog...
- Glenmark gets USFDA nod for post-menopause osteoporosis drugThe approval for sale of Norethindrone Acetate and Ethinyl Estradiol tablets was given to Glenmark Generics Inc USA, a subsidiary of Glenma...
- Roche signs marketing pact with Elder PharmaRoche announced on Thursday that it had signed a marketing agreement with domestic company Elder Pharma for its osteoporosis drug, Bonviva.
Load More
